To Editor:We read with interest the article of Dr. Lima on Malignant Atrophic Papulosis (MAP) or
Degos Disease (DD) [1]. This rare disease
is an occlusive vasculopathy characterized by skin lesions and systemic involvement. DD is
a potentially life-threatening disease, mainly the involvement of inner organs (bowel
perforation and peritonitis, massive cerebral haemorrhage, thrombosis of the cerebral
arteries, encephalitis, meningitis). DD-like skin lesions have occasionally been reported
in association with autoimmune disorders but no specific alterations of laboratory
parameters have been reported in MAP. There are few reports on renal involvement in MAP. We
report our experience on this topic. A 74-year-old male was admitted to hospital for
nephrotic syndrome. Renal biopsy showed a minimal change glomerulopathy. We detect no
vascular lesion. Immunological and microbiological tests were unremarkable. Instrumental
investigations (thorax and abdomen computed-tomography, colonscopy) and malignancy markers
were negative for pathologic findings. Abdominal physical examination disclosed a DD
pathognomonic skin lesion. We observed 0.5-1 large papule with an atrophic porcelain-white
centre and a surrounding erythematous rim. No other lesions on the chest, back,
extremities. Histopathological examination disclosed dermal necrosis without inflammatory
infiltration, calcification and sclerosis in papillary dermis, hyalinosis of the blood
vessel wall in deep layer of the dermis. The patient did not respond to steroid and
cyclophosphamide therapy. After 10 years of follow-up, the skin lesion are unchanged. The
patient continues support therapy for nephritic syndrome without any sign of vasculitic
involvement or new skin change. We believe, in agreement with other Authors, that the lack
of occlusion vessel is a prognostic indicator of benign course of DD.
Authors: Lourenço de Azevedo Lima; Natacha de Carvalho Mello Haddad; Ricardo Barbosa Lima; Antonio Macedo D'Acri; Carlos José Martins Journal: An Bras Dermatol Date: 2014 May-Jun Impact factor: 1.896